Jubilant Pharmova Ltd - 530019 - Board Meeting Intimation for Consideration Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2023.
Jubilant Pharmova Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/07/2023 ,inter alia, to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2023. Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of loss of share certificate under Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Jubilant Pharmova Ltd - 530019 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of letter of confirmation Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We enclose copies of the Audited Standalone and Consolidated Financial Statement of the Company for the quarter and Financial Year ended March 31 2023 published on May 30, 2023 in MINT (English) and HINDUSTAN (Hindi).
Jubilant Pharmova announces leadership changes; Priyavrat Bhartia takes over as MD
Hari S Bhartia has decided to step down from the position of Managing Director of the company effective closing business hours of May 31, 2023 and he shall continue as Co-Chairman, Non-Executive Director on the board of the company, Jubilant Pharmova said in a regulatory filing. Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
We enclose disclosure pertaning to resignation of CFO and Appointment of new CFO Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Resignation of Managing Director
We enclose disclosure pertaning to Resignation of Managing Director and Appointment of Managing Director and Joint Managing Director Jubilant Pharmova Ltd - 530019 - Appointment Of Managing Director And CFO
Appointment of Managing Director and CFO Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Change in Directorate
We enclose disclosure pertaning to Change in Board of Directros and KMP